Literature DB >> 2960770

Evidence for function of Ia molecules on gut epithelial cells in man.

L Mayer1, R Shlien.   

Abstract

Using freshly isolated Ia+ gut epithelial cells we have been able to demonstrate that these cells can function as accessory cells in an immune response. The cells can act as stimulators in both autologous and allogeneic MLRs. More importantly, these cells are capable of taking up the soluble antigen, tetanus toxoid, processing it, and presenting it to tetanus-primed T cells. These functions appear to relate to the presence of surface Ia in that a hetero-anti-Ia antibody can block these effects. Noteworthy is the finding that the subpopulation of T cells stimulated when epithelial cells are used as accessory cells is the T8+, 9.3-T cell. These cells function as potent antigen-nonspecific suppressor cells in both MLR, T cell antigen responses, and induction of B cell differentiation by PWM. These findings have significant implications in local gut immune responses and may help explain several poorly characterized phenomena of mucosal immunity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960770      PMCID: PMC2189639          DOI: 10.1084/jem.166.5.1471

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles.

Authors:  R L Owen; A L Jones
Journal:  Gastroenterology       Date:  1974-02       Impact factor: 22.682

2.  Sensitisation of gut-associated lymphoid tissue during oral immunisation.

Authors:  R Clancy; A Pucci
Journal:  Aust J Exp Biol Med Sci       Date:  1978-06

3.  Isolation and functional characterization of human intestinal mucosal lymphoid cells.

Authors:  D M Bull; M A Bookman
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

4.  Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors.

Authors:  L Mayer; S M Fu; C Cunningham-Rundles; H G Kunkel
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

5.  Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.

Authors:  J A Mattingly; B H Waksman
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

6.  Subpopulations of human lymphoblastoid cell lines. Correlation with the expression of surface receptors and content of Epstein-Barr virus genome.

Authors:  W J Yount; P D Utsinger; L M Hutt; P D Buchanan; J H Korn; C R Fuller; M Logue; J S Pagano
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.

Authors:  T D Geppert; P E Lipsky
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

8.  Human malignant T cells capable of inducing an immunoglobulin class switch.

Authors:  L Mayer; D N Posnett; H G Kunkel
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

9.  Terminal maturation of resting B cells by proliferation-independent B cells differentiation factors.

Authors:  L Mayer
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

10.  Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.

Authors:  R A Vande Stouwe; H G Kunkel; J P Halper; M E Weksler
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  132 in total

1.  Modulatory effect of rat small intestinal epithelial cell-conditioned medium on lymphocyte proliferation.

Authors:  K Tanaka; N Yabe; H Matsui
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-01       Impact factor: 2.416

2.  Factors affecting antigen uptake by human intestinal epithelial cell lines.

Authors:  A L So; G Small; K Sperber; K Becker; E Oei; M Tyorkin; L Mayer
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

3.  Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice.

Authors:  A S Major; C F Cuff
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Expression of the thymus leukemia antigen in mouse intestinal epithelium.

Authors:  R Hershberg; P Eghtesady; B Sydora; K Brorson; H Cheroutre; R Modlin; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  CD4+ T regulatory cells from the colonic lamina propria of normal mice inhibit proliferation of enterobacteria-reactive, disease-inducing Th1-cells from scid mice with colitis.

Authors:  M Gad; J Brimnes; M H Claesson
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 6.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

7.  Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids.

Authors:  A E Stoop; H A van der Heijden; J Biewenga; S van der Baan
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 8.  The microbiome and regulation of mucosal immunity.

Authors:  Andrew J McDermott; Gary B Huffnagle
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

9.  Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system.

Authors:  E Furrie; M W Turner; S Strobel
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

10.  Class II MHC antigens in the rat digestive system. Normal distribution and induced expression after interferon-gamma treatment in vivo.

Authors:  B Steiniger; P Falk; M Lohmüller; P H van der Meide
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.